Catalyst Wire Dossier Catalyst Wire Dossier

CRENESSITY

crinecerfont · Neurocrine Biosciences, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CRENESSITY, covering 2024-12-13 to 2024-12-13. Get the full timeline:

Most recent: FDA Approved: CRENESSITY — Original Application (Neurocrine Biosciences, Inc.)

See pricing